AGN Insider Trading Activity and SEC Form 4 Filings
AGN insider trading summary
No open-market insider purchases or sales of Allergan plc (AGN) have been reported on SEC Form 4 in the past 12 months.
Latest AGN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 7, 2019 | Brent L Saunders | Chairman, President and CEO | Buy | $87K (600 @ $144.37) |
| Mar 7, 2019 | Brent L Saunders | Chairman, President and CEO | Buy | $43K (300 @ $142.18) |
| Mar 7, 2019 | Brent L Saunders | Chairman, President and CEO | Buy | $124K (860 @ $143.70) |
| Nov 16, 2018 | Matthew M Walsh | EVP, Chief Financial Officer | Buy | $157K (1,000 @ $157.00) |
| Sep 6, 2018 | Christopher J Coughlin | Director | Buy | $76K (400 @ $190.60) |
| Sep 6, 2018 | Christopher J Coughlin | Director | Buy | $19K (100 @ $190.65) |
| Sep 6, 2018 | Christopher J Coughlin | Director | Buy | $68K (356 @ $190.59) |
| Sep 6, 2018 | Christopher J Coughlin | Director | Buy | $5K (27 @ $190.57) |
| Sep 6, 2018 | Christopher J Coughlin | Director | Buy | $134K (705 @ $190.56) |
| Sep 6, 2018 | Christopher J Coughlin | Director | Buy | $248K (1,300 @ $190.55) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.